Navigation Links
Exelixis Presents Encouraging Phase 1 Data For XL019, A Novel Selective Inhibitor of JAK2
Date:12/10/2007

erability of XL019 when administered orally once daily for 21 days in 28-day cycles. Secondary objectives include evaluation of the pharmacokinetics and pharmacodynamics of XL019, and to evaluate response using the International Working Group for MF consensus response criteria.

Results To-Date

Data (unaudited) from cohort 1 (100mg), cohort 2 (200mg) and cohort 3 (300mg) were presented today and the key findings by investigators include:

-- Preliminary clinical activity observed in most subjects, including:

- Reduction in spleen size of 33 to 100% in five of six patients

evaluated

- Reduction in erythropoietin-independent colony formation of up to

39% and up to 100% in two patients evaluated

-- Relief of constitutional symptoms, including pruritus, fatigue, back

pain and abdominal fullness

-- Reduction in the number of cells with the JAK2 V617F mutation (allele

burden)

-- Correlation between XL019 exposure and decreases in phosphorylation of

STAT, a marker for JAK activity.

-- XL019 was generally well tolerated.

- Adverse events included Grade 1 nausea, headaches, equilibrium

imbalance, dizziness, chest discomfort, visual disturbances, fatigue

and hypertension.

- Grade 2 AEs of lightheadedness and decreased sensation in soles and

one serious adverse event of confusion in a patient with baseline

history of dementia were also observed.

-- No evidence of myelosuppression

The maximum tolerated dose has not been reached. The phase 1 dose escalating clinical trial continues.

About JAK2 and XL019

JAK kinases are activated by cytokines and growth factor receptors and phosphorylate members of the STAT family of inducible transcription factors. JAK2 plays a pivotal role in the cellular response to growth factors that drive blood cell expansion, including erythrop
'/>"/>

SOURCE Exelixis, Inc.
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. GlaxoSmithKline Accelerates Review of Exelixis XL880
2. Exelixis Announces September 5 Webcast of Its 2007 IASLC Investor and Analyst Briefing
3. Exelixis Reports Top-Line Results of the Phase 2 Trial of XL784 in Patients With Proteinuria Associated With Diabetic Nephropathy
4. Updated Phase 1 Data for Exelixis XL184 Demonstrate Pharmacodynamic and Clinical Anti-Tumor Activity
5. Exelixis Reports XL647 Clinical Data at AACR-NCI-EORTC Conference
6. Interim Phase 2 Data for Exelixis XL880 Show Anti-Tumor Activity in Papillary Renal Cell Cancer
7. Phase 2 Trial Results for Exelixis XL784 Presented at the 2007 American Society of Nephrology Conference
8. Genaera Corporation Presents Interim Phase 1 Data for Obesity Compound Trodusquemine (MSI-1436) at IBC Conference
9. EntreMed Presents Data for Phase 2 Study of MKC-1 in Metastatic Breast Cancer
10. Pharmasset Presents R7128 Phase 1 Single Ascending Dose Study in Healthy Volunteers
11. Anadys Pharmaceuticals Presents Preclinical Results on ANA598, a Non-Nucleoside Inhibitor of the NS5B Polymerase, at the 14th International Symposium on Hepatitis C Virus and Related Viruses
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/21/2014)... Ontario , Nov. 20, 2014  RedRick ... mounting solutions and reading room environment guidance, has ... newest musculoskeletal radiology reading room, which may also ... designs at Penn Medicine. "In ... the American College of Radiology,s Imaging 3.0 ™ ...
(Date:11/21/2014)... CORAL GABLES, Fla. , Nov. 20, 2014 /PRNewswire/ ... working to become the first U.S. commercial producer of ... signed a contract with INVAP to design ... Alachua, Fla. Mo-99 is the parent isotope ... nuclear medicine procedures worldwide. In 2012, Congress passed legislation ...
(Date:11/18/2014)...  NxStage ® Medical Inc. (Nasdaq: ... innovative dialysis products , today announced the launch ... the in-center, hemodialysis market.  Streamline Express features a ... reduce the amount of labor required for machine ... point contamination sites.  The dialyzer enables achievement of ...
Breaking Medicine Technology:RedRick Technologies Helps Penn Radiology Implement New Radiology Reading Room Concepts 2RedRick Technologies Helps Penn Radiology Implement New Radiology Reading Room Concepts 3Coqui RadioPharmaceuticals Inks Deal With INVAP 2NxStage Launches New Streamline Express Dialyzer With Pre-attached Blood Tubing Set 2
... Worldwide -- Leading events organiser UBM Live , ... introduction of a new event, ICSE USA, to be held ... Philadelphia. ICSE USA extends an established global line-up of International ... will focus on the pharmaceutical contract services and outsourcing sectors ...
... INNOPHARMA LLC announced today FDA approval of its Abbreviated New ... Zyprexa® injection). As the developer of this generic ... pursuant to which Sandoz will sell, market and distribute the ... About INNOPHARMA: INNOPHARMA is a sterile product ...
Cached Medicine Technology:UBM Live to Roll Out Pharma Contract Services & Outsourcing Brand in the US in 2012 2UBM Live to Roll Out Pharma Contract Services & Outsourcing Brand in the US in 2012 3
(Date:11/21/2014)... TruDenta, the creator of a diagnostic ... other jaw-related symptoms, has reported a nationwide rise in ... pain, neck pain, TMJ (temporomandibular joint) disorder, jaw pain, ... seen a 52% increase in the number of patients ... doctors and their teams in 47 states are changing ...
(Date:11/21/2014)... DressVe.com , a renowned women’s dress wholesaler and retailer in ... accessories. Furthermore, the company has launched its Special Black Friday ... its fashion items. Also, orders above $59 are qualified for ... their wedding dresses and prom dresses are very popular in ... , The CEO says “We are glad to introduce ...
(Date:11/21/2014)... Recently, TideStore.com, a leading online store ... its special offer TideStore Thanksgiving Sales . According ... are now provided with big discounts. The special offer ... enjoy an extra 10% discount with this coupon code: ... and have opportunities to win free gifts. TideStore.com has ...
(Date:11/21/2014)... MO (PRWEB) November 21, 2014 ... Melancholy Lift, an industry leader in the ... people have significant feelings of sadness and depression ... from traditional pharmaceutical choices. Often, prescription drugs can ... depression. Prescription drugs are expensive and require regular ...
(Date:11/21/2014)... (PRWEB) November 21, 2014 RankingBySEO has ... manage the online reputation of lawyers, and the company ... has announced the service for lawyers since it receives ... online reputation in big numbers. So far, the company ... and law firms in different parts of the world, ...
Breaking Medicine News(10 mins):Health News:National Rise In Patients Seeking Headache Relief 2Health News:DressVe.com Announces Its 2014 Special Friday Sales 2Health News:Thanksgiving Sales from TideStore.com 2Health News:Depression Relief Product Receives Top 5-Star Rating from TopConsumerReviews.com 2Health News:RankingBySEO Announces Lawyer Reputation Management Service 2
... receive treatment have a greater risk of developing blood clots, ... the necessary steps to prevent the clots from forming.// ... determine if the doctors were aware of the risk of ... physicians. About 40 percent of the doctors who were surveyed ...
... the brain become blocked. A silent stroke does not cause ... risk of a future stroke.// A new study shows having ... a silent stroke. ,For the study, researchers conducted MRIs ... of the patients had high blood pressure but did not ...
... the journal Science dealt only with laboratory fruit flies, but ... mammals, perhaps even humans.// ,In the study, British ... mortality of fruit flies. They found that fruit flies on ... those fed on a normal diet. ,But ...
... use indoor tanning booths than boys and to use them ... ,The study found nearly 37 percent of white teenage girls ... nearly 30 percent of them reported using a tanning booth ... tanning booths increased with age. The rate was 11.2 per ...
... Physicians typically use medication to treat patients suffering from ... May 2001 issue of the Journal of the American ... stop smoking can have just as powerful an impact ... patients have had significant heart damage from previous heart ...
... screening technologies have become regularly used to detect masses in the ... Once a mass is detected, a biopsy may follow to ... need a breast biopsy. Now, doctors have a new way to ... ,With three sons, Daria Pistelli has plenty of men in her ...
Cached Medicine News:Health News:Risks for Silent Strokes 2Health News:Even mid-life diet change can extend life, 2Health News:,Girls Hit Tanning Booths More Than Boys 2Health News:It's Never Too Late to Stop Smoking,Study Finds , 2
The APR Hip System offers a complete line of stems to precisely match patients' anatomic needs and address surgeon preferences....
Dual offset femoral stems, hip stems that provide unique and competitive features....
The Link SP II Hip stem for cemented revisions...
The proximally modular S-ROM Total Hip System provides custom capability at non-custom prices and is competitive with conventional porous coated systems....
Medicine Products: